| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |